Post-COVID-19 Pulmonary Fibrosis-Reference-Cited by-同舟云学术

Post-COVID-19 Pulmonary Fibrosis

Published:2022-03-02 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Mohammadi Asma,Balan Irina,Yadav Shikha,Matos Wanessa F,Kharawala Amrin,Gaddam Mrunanjali,Sarabia Noemi,Koneru Sri Charitha,Suddapalli Siva K,Marzban Sima

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference62 articles.

1. The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies;Hosseini ES;Virology,2020

2. A novel coronavirus from patients with pneumonia in China, 2019;Zhu N;N Engl J Med,2020

3. First case of 2019 novel coronavirus in the United States;Holshue ML;N Engl J Med,2020

4. WHO declares COVID-19 a pandemic;Cucinotta D;Acta Biomed,2020

5. Coronavirus resource center, COVID-19 Dashboard. (2021). Accessed. August 20, 2021: https://coronavirus.jhu.edu/map.html.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liberation from extracorporeal membrane oxygenation in a patient with severe COVID-19-associated acute respiratory distress syndrome using traditional Chinese medicine: A case report;EXPLORE;2024-11

2. Impact of anti-fibrotic medications on post-COVID-19 pulmonary fibrosis: A systematic review and meta-analysis;International Journal of Infectious Diseases;2024-10

3. Harmine inhibits pulmonary fibrosis through regulating DNA damage repair-related genes and activation of TP53-Gadd45α pathway;International Immunopharmacology;2024-09

4. Rosuvastatin ameliorates chemically induced acute lung injury in rats by targeting ferroptosis, heat shock protein B1, and inflammation;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-27

5. Synthetic Amphipathic Helical Peptide L-37pA Ameliorates the Development of Acute Respiratory Distress Syndrome (ARDS) and ARDS-Induced Pulmonary Fibrosis in Mice;International Journal of Molecular Sciences;2024-08-01